Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterising the Pharmacokinetics of Tafenoquine Under Fed Conditions for Plasmodium Vivax Radical Cure in Children ≤12kg and >28 Days Old

NCT07835321 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT07835321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07835321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterising the Pharmacokinetics of Tafenoquine Under Fed Conditions for Plasmodium Vivax Radical Cure in Children ≤12kg and >28 Days Old
Lead sponsor
University of Oxford
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
April 30, 2030
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

plasmodium vivax malaria, vivax malaria